US BANCORP \DE\ - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 124 filers reported holding CARDLYTICS INC in Q4 2022. The put-call ratio across all filers is 1.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$1,452
-51.6%
88
-72.8%
0.00%
Q3 2022$3,000
-66.7%
323
-19.0%
0.00%
Q2 2022$9,000
+350.0%
399
+1008.3%
0.00%
Q1 2022$2,000
-50.0%
36
-42.9%
0.00%
Q4 2021$4,000
-82.6%
63
-77.0%
0.00%
Q3 2021$23,000
-25.8%
274
+13.2%
0.00%
Q2 2021$31,000
+287.5%
242
+245.7%
0.00%
Q1 2021$8,000
-38.5%
70
-21.3%
0.00%
Q4 2020$13,000
+116.7%
89
+6.0%
0.00%
Q3 2020$6,000
+500.0%
84
+460.0%
0.00%
Q2 2020$1,000150.00%
Other shareholders
CARDLYTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders